Cholinesterase inhibitors and Alzheimer's disease outcomes.
Garcia
Angeles
A
Thompson
Kelli
K
Zanibbi
Katherine
K
Geick
Shannon
S
Adams
Rachel
R
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000175:diagnosis* / Q000453:epidemiology; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015994:Incidence; D007326:Institutionalization; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012720:Severity of Illness Index; D012737:Sex Factors; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors